Nifty

:

26172.40

Sensex

:

85567.48

206.00 (0.79%)
638.12 (0.75%)

Login

Nifty
Sensex

:
:

26172.40
85567.48

206.00 (0.79%)
638.12 (0.75%)

Dishman Carbogen Amcis Ltd.

Pharmaceuticals & Drugs - Global

Rating :

56/99

BSE: 540701 | NSE: DCAL

Watchlist

NSE BSE

255.74

22-Dec-2025

Open
High
Low
Previous Close

245.45
257.5
241.79
242.96

Volume
Traded Value (lacs)
52 Week High
52 Week Low

297181
74657273.39
321.95
178

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,005.81
29.37
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,634.37
N/A
0.63

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

50.27
7.24
3.97

EBITDA CAGR (%)

10 Years
5 Years
3 Years

45.57
9.91
5.77

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-46.55
-44.86

P:E (Median)

8 Years
5 Years
3 Years

6.43
-
-

P:BV (Average)

8 Years
5 Years
3 Years

0.84
0.97
1.33

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.05
11.38
12.81

Earnings Forecasts:

(Updated: 20-12-2025)

Description 2024 2025 2026 2027
Adj EPS 0.21
P/E Ratio 1217.81
Revenue 2711.5
EBITDA 480.46
Net Income 3.24
ROA 0.03
P/B Ratio 0.69
ROE 0.06
FCFF 9.74
FCFF Yield 0.16
Net Debt 1856.49
BVPS 371.91

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 60.30 93.29 -35.36% 62.86 103.41 -39.21% 106.10 111.26 -4.64% 97.04 86.82 11.77%
Expenses 55.89 79.89 -30.04% 59.43 88.51 -32.86% 85.57 99.69 -14.16% 74.08 83.65 -11.44%
EBITDA 4.41 13.40 -67.09% 3.43 14.90 -76.98% 20.53 11.57 77.44% 22.96 3.17 624.29%
EBIDTM 7.31% 14.36% 5.46% 14.41% 19.35% 10.40% 23.66% 3.65%
Other Income 11.17 23.93 -53.32% 37.42 11.59 222.86% 5.47 -3.21 - -8.01 13.11 -
Interest 20.61 15.59 32.20% 20.26 15.73 28.80% 21.31 15.87 34.28% 17.77 17.14 3.68%
Depreciation 15.79 16.30 -3.13% 16.47 16.32 0.92% 16.10 26.12 -38.36% 16.48 26.22 -37.15%
PBT -20.82 5.44 - 4.12 -5.56 - -11.41 -33.63 - -19.30 -27.08 -
Tax -7.22 -8.81 - 1.45 -2.09 - -4.04 -2.51 - -6.02 -8.90 -
PAT -13.60 14.25 - 2.67 -3.47 - -7.37 -31.12 - -13.28 -18.18 -
PATM -22.55% 15.27% 4.25% -3.36% -6.95% -27.97% -13.69% -20.94%
EPS -0.87 0.91 - 0.17 -0.22 - -0.47 -1.98 - -0.85 -1.16 -

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 652.65 789.04 -17.29% 708.05 523.78 35.18% 716.34 654.71 9.41% 682.34 651.09 4.80%
Expenses 503.76 641.89 -21.52% 567.37 494.81 14.66% 563.65 592.03 -4.79% 542.21 609.98 -11.11%
EBITDA 148.89 147.15 1.18% 140.68 28.97 385.61% 152.69 62.68 143.60% 140.13 41.11 240.87%
EBIDTM 22.81% 18.65% 19.87% 5.53% 21.32% 9.57% 20.54% 6.31%
Other Income 8.11 6.65 21.95% 24.75 1.43 1,630.77% 7.97 7.16 11.31% 5.63 6.05 -6.94%
Interest 42.33 36.63 15.56% 42.76 31.93 33.92% 42.12 30.95 36.09% 48.78 33.08 47.46%
Depreciation 84.13 72.09 16.70% 81.35 70.59 15.24% 79.09 85.00 -6.95% 71.97 80.37 -10.45%
PBT 30.54 42.12 -27.49% 38.67 -77.56 - 27.70 -49.20 - 27.05 -66.29 -
Tax -34.73 9.03 - 15.26 0.01 1,52,500.00% -15.39 20.72 - 22.42 -6.66 -
PAT 65.27 33.09 97.25% 23.41 -77.57 - 43.09 -69.92 - 4.63 -59.63 -
PATM 10.00% 4.19% 3.31% -14.81% 6.02% -10.68% 0.68% -9.16%
EPS 4.16 2.11 97.16% 1.49 -4.95 - 2.75 -4.46 - 0.30 -3.80 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 326.30 399.84 327.35 402.55 306.61 200.32 580.74 549.47 474.46 451.49 6.81 Net Sales Growth -17.35% 22.14% -18.68% 31.29% 53.06% -65.51% 5.69% 15.81% 5.09% 6529.81% Cost Of Goods Sold 81.04 131.01 115.97 171.35 99.41 97.58 200.11 162.58 155.31 142.07 0.00 Gross Profit 245.26 268.83 211.38 231.20 207.20 102.74 380.63 386.89 319.15 309.42 6.81 GP Margin 75.16% 67.23% 64.57% 57.43% 67.58% 51.29% 65.54% 70.41% 67.27% 68.53% 100% Total Expenditure 274.97 328.05 320.55 394.79 272.82 253.11 407.18 355.68 315.57 303.36 5.13 Power & Fuel Cost - 32.16 28.71 33.07 24.83 12.78 35.27 31.44 28.48 26.36 0.00 % Of Sales - 8.04% 8.77% 8.22% 8.10% 6.38% 6.07% 5.72% 6.00% 5.84% 0% Employee Cost - 90.15 91.54 86.13 79.04 58.23 88.87 80.27 61.67 66.76 0.00 % Of Sales - 22.55% 27.96% 21.40% 25.78% 29.07% 15.30% 14.61% 13.00% 14.79% 0% Manufacturing Exp. - 27.19 38.08 43.20 30.48 22.70 37.31 40.40 23.46 27.03 0.00 % Of Sales - 6.80% 11.63% 10.73% 9.94% 11.33% 6.42% 7.35% 4.94% 5.99% 0% General & Admin Exp. - 39.75 32.40 31.28 30.43 21.08 24.91 31.58 22.42 27.66 5.08 % Of Sales - 9.94% 9.90% 7.77% 9.92% 10.52% 4.29% 5.75% 4.73% 6.13% 74.60% Selling & Distn. Exp. - 5.34 3.76 9.27 7.68 4.10 7.18 5.38 10.65 8.51 0.00 % Of Sales - 1.34% 1.15% 2.30% 2.50% 2.05% 1.24% 0.98% 2.24% 1.88% 0% Miscellaneous Exp. - 2.45 10.09 20.49 0.95 36.64 13.53 4.03 13.58 4.97 0.00 % Of Sales - 0.61% 3.08% 5.09% 0.31% 18.29% 2.33% 0.73% 2.86% 1.10% 0.73% EBITDA 51.33 71.79 6.80 7.76 33.79 -52.79 173.56 193.79 158.89 148.13 1.68 EBITDA Margin 15.73% 17.95% 2.08% 1.93% 11.02% -26.35% 29.89% 35.27% 33.49% 32.81% 24.67% Other Income 46.05 32.98 63.05 52.16 66.11 66.29 69.57 71.68 73.07 70.80 0.32 Interest 79.95 70.40 68.19 57.92 37.23 34.17 47.02 47.43 35.34 39.17 0.99 Depreciation 64.84 65.20 101.61 96.20 140.07 141.35 140.65 136.31 134.45 135.85 0.00 PBT -47.41 -30.83 -99.95 -94.20 -77.40 -162.02 55.46 81.73 62.17 43.91 1.01 Tax -15.83 -20.96 -26.59 -37.33 -52.84 64.12 16.94 25.72 25.10 19.67 0.12 Tax Rate 33.39% 67.99% 25.82% 38.80% 63.43% -39.58% 30.54% 31.47% 40.37% 44.80% 11.88% PAT -31.58 -9.87 -76.41 -58.87 -30.47 -226.14 38.52 56.01 37.07 24.24 0.89 PAT before Minority Interest -31.58 -9.87 -76.41 -58.87 -30.47 -226.14 38.52 56.01 37.07 24.24 0.89 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -9.68% -2.47% -23.34% -14.62% -9.94% -112.89% 6.63% 10.19% 7.81% 5.37% 13.07% PAT Growth 0.00% - - - - - -31.23% 51.09% 52.93% 2,623.60% EPS -2.01 -0.63 -4.87 -3.75 -1.94 -14.42 2.46 3.57 2.36 1.55 0.06

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 2,759.38 2,711.50 2,615.77 2,412.92 2,140.69 1,912.03 2,043.60 2,058.60 1,694.79 1,713.69 Net Sales Growth 5.38% 3.66% 8.41% 12.72% 11.96% -6.44% -0.73% 21.47% -1.10% Cost Of Goods Sold 377.14 501.64 597.19 516.82 447.42 468.15 458.72 403.78 336.93 329.30 Gross Profit 2,382.24 2,209.86 2,018.58 1,896.10 1,693.27 1,443.88 1,584.88 1,654.82 1,357.86 1,384.39 GP Margin 86.33% 81.50% 77.17% 78.58% 79.10% 75.52% 77.55% 80.39% 80.12% 80.78% Total Expenditure 2,176.99 2,271.77 2,351.85 2,080.72 1,815.04 1,637.82 1,546.04 1,506.70 1,256.77 1,260.34 Power & Fuel Cost - 92.20 104.29 87.57 62.58 41.28 60.26 56.79 48.67 49.74 % Of Sales - 3.40% 3.99% 3.63% 2.92% 2.16% 2.95% 2.76% 2.87% 2.90% Employee Cost - 1,293.57 1,208.16 1,029.86 981.49 872.91 762.27 714.64 625.40 596.02 % Of Sales - 47.71% 46.19% 42.68% 45.85% 45.65% 37.30% 34.71% 36.90% 34.78% Manufacturing Exp. - 166.79 209.66 171.92 144.91 118.31 118.03 114.69 83.69 98.02 % Of Sales - 6.15% 8.02% 7.12% 6.77% 6.19% 5.78% 5.57% 4.94% 5.72% General & Admin Exp. - 157.05 159.87 142.69 104.71 82.76 90.42 157.80 112.15 81.58 % Of Sales - 5.79% 6.11% 5.91% 4.89% 4.33% 4.42% 7.67% 6.62% 4.76% Selling & Distn. Exp. - 32.72 24.80 35.47 29.44 21.94 23.40 20.90 18.56 58.54 % Of Sales - 1.21% 0.95% 1.47% 1.38% 1.15% 1.15% 1.02% 1.10% 3.42% Miscellaneous Exp. - 27.80 47.88 96.39 44.49 32.47 32.94 38.10 31.37 47.14 % Of Sales - 1.03% 1.83% 3.99% 2.08% 1.70% 1.61% 1.85% 1.85% 2.75% EBITDA 582.39 439.73 263.92 332.20 325.65 274.21 497.56 551.90 438.02 453.35 EBITDA Margin 21.11% 16.22% 10.09% 13.77% 15.21% 14.34% 24.35% 26.81% 25.85% 26.45% Other Income 46.46 50.89 50.79 27.77 49.14 38.59 44.46 53.82 53.02 26.13 Interest 175.99 159.46 119.97 85.69 56.81 47.61 61.95 56.55 48.83 49.01 Depreciation 316.54 293.74 310.86 280.72 307.59 307.94 282.87 240.38 211.42 213.50 PBT 123.96 37.42 -116.12 -6.44 10.39 -42.75 197.20 308.79 230.79 216.97 Tax -12.44 16.07 31.19 -24.79 -22.26 100.10 38.69 98.46 76.22 70.65 Tax Rate -10.04% 83.22% -25.51% 45.41% 523.76% -153.93% 19.62% 31.89% 33.03% 32.56% PAT 136.40 3.24 -153.45 -29.80 18.01 -165.13 158.51 210.33 154.57 146.32 PAT before Minority Interest 136.40 3.24 -153.45 -29.80 18.01 -165.13 158.51 210.33 154.57 146.32 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.94% 0.12% -5.87% -1.24% 0.84% -8.64% 7.76% 10.22% 9.12% 8.54% PAT Growth 178.38% - - - - - -24.64% 36.07% 5.64% EPS 8.70 0.21 -9.79 -1.90 1.15 -10.53 10.11 13.41 9.86 9.33

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 4,030.48 4,052.58 4,114.31 4,231.78 4,674.62 4,795.85 4,892.37 4,791.58 4,770.74 0.33 Share Capital 31.36 31.36 31.36 31.36 31.36 31.38 32.28 32.28 0.00 0.05 Total Reserves 3,999.12 4,021.22 4,082.95 4,200.42 4,643.26 4,764.47 4,860.09 4,759.30 -39.26 0.28 Non-Current Liabilities 586.89 552.47 572.25 578.46 493.37 494.60 397.81 651.80 364.95 8.98 Secured Loans 227.52 157.37 162.57 134.42 144.41 137.90 202.73 279.37 144.62 0.00 Unsecured Loans 20.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.98 Long Term Provisions 153.60 154.10 154.06 154.80 154.38 185.00 8.03 166.38 6.59 0.00 Current Liabilities 652.10 618.73 641.60 551.19 530.88 620.44 525.93 520.87 401.16 2.80 Trade Payables 71.99 115.88 85.34 53.82 54.42 85.92 93.68 88.15 58.14 0.00 Other Current Liabilities 281.30 182.62 174.55 219.77 186.18 191.52 144.15 173.91 85.45 2.65 Short Term Borrowings 296.51 318.44 379.79 275.70 288.24 340.97 283.88 256.97 256.31 0.00 Short Term Provisions 2.30 1.79 1.92 1.90 2.04 2.03 4.22 1.84 1.26 0.15 Total Liabilities 5,269.47 5,223.78 5,328.16 5,361.43 5,698.87 5,910.89 5,816.11 5,964.25 5,536.85 12.11 Net Block 1,401.20 1,415.63 1,382.30 1,355.98 1,509.65 1,632.53 1,715.32 1,852.82 1,927.08 0.00 Gross Block 2,622.14 2,572.51 2,456.61 2,338.73 2,364.26 2,344.45 2,286.96 2,293.17 2,233.75 0.00 Accumulated Depreciation 1,220.94 1,156.88 1,074.31 982.75 854.61 711.92 571.64 440.35 306.67 0.00 Non Current Assets 4,594.49 4,636.56 4,678.55 4,595.64 4,975.81 5,146.20 5,079.83 5,210.82 4,767.34 0.00 Capital Work in Progress 40.70 74.05 142.89 117.77 121.20 88.85 69.78 47.89 40.55 0.00 Non Current Investment 2,824.85 2,834.26 2,837.36 2,811.09 2,814.87 2,843.10 2,886.97 2,842.75 2,593.82 0.00 Long Term Loans & Adv. 325.95 311.95 315.19 310.14 529.74 576.27 406.44 462.42 191.96 0.00 Other Non Current Assets 1.79 0.67 0.81 0.66 0.35 5.45 1.32 4.94 13.93 0.00 Current Assets 674.98 587.22 649.61 765.79 723.06 764.69 736.28 753.43 769.51 12.11 Current Investments 16.04 13.90 75.49 221.19 66.84 57.01 19.72 94.35 167.37 0.00 Inventories 134.25 169.62 182.66 196.90 184.40 213.64 222.61 169.09 151.80 0.00 Sundry Debtors 174.75 183.70 146.80 65.66 118.89 144.90 130.15 140.02 71.18 0.00 Cash & Bank 87.41 9.90 68.43 86.47 80.32 65.13 47.35 21.29 40.31 0.60 Other Current Assets 262.53 29.30 29.76 52.44 272.61 284.01 316.45 328.68 338.85 11.51 Short Term Loans & Adv. 232.95 180.80 146.47 143.13 180.90 230.24 224.13 261.20 285.81 10.81 Net Current Assets 22.88 -31.51 8.01 214.60 192.18 144.25 210.35 232.56 368.35 9.31 Total Assets 5,269.47 5,223.78 5,328.16 5,361.43 5,698.87 5,910.89 5,816.11 5,964.25 5,536.85 12.11

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 5,831.52 5,627.50 5,809.67 5,548.94 5,698.82 5,715.06 5,379.09 5,107.33 4,813.98 Share Capital 31.36 31.36 31.36 31.36 31.36 31.38 32.28 32.28 0.00 Total Reserves 5,800.16 5,596.14 5,778.31 5,517.58 5,667.46 5,683.68 5,346.81 5,075.05 3.98 Non-Current Liabilities 2,230.03 1,388.40 1,831.43 1,665.47 1,366.74 909.40 743.13 883.95 766.66 Secured Loans 1,129.02 245.61 1,046.65 761.96 503.94 222.41 310.55 386.16 241.45 Unsecured Loans 20.17 0.00 0.00 0.00 0.00 18.89 51.87 138.81 218.67 Long Term Provisions 352.43 379.04 233.16 277.09 310.99 294.08 248.31 234.34 221.40 Current Liabilities 1,924.79 2,554.72 1,798.39 1,419.79 1,290.30 1,568.95 1,198.31 1,177.72 993.66 Trade Payables 230.68 244.12 219.73 193.37 169.23 283.52 194.57 185.92 85.64 Other Current Liabilities 993.23 639.53 841.64 702.41 558.68 578.83 430.36 515.88 457.19 Short Term Borrowings 655.35 1,620.23 680.76 492.64 542.47 688.23 520.09 393.31 384.95 Short Term Provisions 45.53 50.84 56.26 31.37 19.92 18.37 53.29 82.61 65.88 Total Liabilities 9,986.34 9,570.62 9,439.49 8,634.20 8,355.86 8,193.41 7,320.53 7,169.00 6,574.30 Net Block 7,050.72 6,720.08 6,183.17 5,768.14 5,693.34 5,672.85 5,092.37 5,060.70 4,847.25 Gross Block 10,545.34 10,308.48 9,457.72 8,633.43 8,155.29 7,890.70 6,896.88 6,621.19 6,187.07 Accumulated Depreciation 3,494.62 3,588.40 3,274.55 2,865.29 2,461.95 2,217.85 1,804.51 1,560.49 1,339.82 Non Current Assets 7,785.92 7,642.43 7,521.13 6,795.48 6,651.72 6,414.44 5,766.95 5,622.85 5,241.25 Capital Work in Progress 466.84 645.74 1,043.25 779.51 485.78 234.17 175.25 150.71 132.88 Non Current Investment 71.96 78.85 72.10 31.83 55.78 89.09 152.61 106.60 44.25 Long Term Loans & Adv. 190.47 192.78 217.24 210.78 411.53 412.88 345.40 299.33 200.63 Other Non Current Assets 1.79 0.66 0.81 0.66 0.35 5.45 1.32 5.51 16.24 Current Assets 2,200.42 1,928.19 1,918.36 1,838.72 1,704.14 1,778.97 1,553.58 1,546.15 1,333.05 Current Investments 25.43 23.29 176.97 292.53 116.44 106.61 19.72 94.35 0.00 Inventories 900.24 882.89 803.80 645.12 515.65 580.87 548.62 484.56 426.58 Sundry Debtors 665.14 484.47 589.91 473.42 420.71 577.43 445.30 444.40 285.55 Cash & Bank 507.03 413.35 189.17 172.09 307.74 160.98 95.67 69.06 87.39 Other Current Assets 102.58 45.15 37.54 66.08 343.60 353.08 444.27 453.78 533.53 Short Term Loans & Adv. 80.17 79.04 120.97 189.48 197.57 277.10 309.17 373.27 361.20 Net Current Assets 275.63 -626.53 119.97 418.93 413.84 210.02 355.27 368.43 339.39 Total Assets 9,986.34 9,570.62 9,439.49 8,634.20 8,355.86 8,193.41 7,320.53 7,169.00 6,574.30

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 55.81 24.17 -52.90 227.35 -1.51 196.68 119.73 20.05 270.38 2.57 PBT -30.83 -103.00 -96.20 -84.39 -168.69 55.46 81.73 62.17 43.91 1.01 Adjustment 95.67 116.86 100.96 117.32 128.11 135.32 122.26 106.13 84.59 0.71 Changes in Working Capital -6.76 11.53 -54.11 200.55 46.25 24.14 -64.57 -122.65 179.09 0.97 Cash after chg. in Working capital 58.08 25.39 -49.35 233.48 5.67 214.92 139.42 45.65 307.59 2.69 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.27 -1.22 -3.55 -6.13 -7.18 -18.24 -19.69 -25.60 -37.21 -0.12 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -79.64 96.57 40.71 -172.67 62.07 -74.30 -24.17 -174.61 -19.15 0.28 Net Fixed Assets -16.28 -47.06 -143.00 28.96 -52.16 -76.56 -15.68 -66.76 -2,274.30 0.00 Net Investments 7.27 64.69 119.43 -150.57 18.40 6.58 30.41 -175.91 -2,761.19 0.00 Others -70.63 78.94 64.28 -51.06 95.83 -4.32 -38.90 68.06 5,016.34 0.28 Cash from Financing Activity 87.51 -130.76 1.38 -46.16 -70.53 -124.07 -85.32 142.45 -225.38 -2.28 Net Cash Inflow / Outflow 63.68 -10.02 -10.81 8.52 -9.97 -1.69 10.24 -12.11 25.85 0.57 Opening Cash & Equivalents 4.05 14.07 24.88 16.36 26.33 28.01 17.77 29.86 0.58 0.01 Closing Cash & Equivalent 67.73 4.05 14.07 24.88 16.36 26.32 28.01 17.75 29.86 0.58

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 375.23 379.43 265.95 354.85 512.66 585.14 282.03 226.44 302.65 PBT 19.31 -122.26 -54.59 -4.25 -65.03 197.20 308.79 230.79 216.08 Adjustment 466.83 376.83 392.46 325.36 312.54 330.11 277.24 235.49 231.80 Changes in Working Capital -80.59 143.83 -37.73 90.08 316.35 132.23 -174.47 -206.26 -29.43 Cash after chg. in Working capital 405.55 398.40 300.14 411.19 563.86 659.54 411.56 260.02 418.45 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -30.32 -18.97 -34.19 -56.34 -51.20 -74.40 -129.53 -33.58 -115.80 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -192.21 -229.52 -494.08 -618.53 -380.02 -441.74 -169.02 -297.16 -142.41 Net Fixed Assets -16.28 -47.06 -143.00 28.96 -52.16 -76.56 -15.68 -66.76 Net Investments 7.27 64.69 119.43 -150.57 18.40 6.58 30.41 -175.91 Others -183.20 -247.15 -470.51 -496.92 -346.26 -371.76 -183.75 -54.49 Cash from Financing Activity -102.09 -22.15 249.68 130.37 -11.04 -97.78 -102.20 77.63 -137.08 Net Cash Inflow / Outflow 80.93 127.76 21.55 -133.31 121.60 45.62 10.81 6.91 23.16 Opening Cash & Equivalents 264.09 131.79 110.24 243.55 121.94 76.32 65.52 58.61 0.00 Closing Cash & Equivalent 341.07 264.09 131.79 110.24 243.54 121.94 76.33 65.52 58.61

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 257.05 258.46 262.39 269.88 298.13 305.66 303.12 296.88 0.00 13.20 ROA -0.19% -1.45% -1.10% -0.55% -3.90% 0.66% 0.96% 0.64% 0.87% 7.29% ROE -0.24% -1.87% -1.41% -0.68% -4.78% 0.80% 1.16% 1.56% 0.00% 0.00% ROCE 0.85% -0.75% -0.81% -0.93% -2.42% 1.89% 2.37% 1.83% 3.18% 21.05% Fixed Asset Turnover 0.15 0.13 0.17 0.13 0.09 0.25 0.24 0.21 0.20 0.00 Receivable days 163.61 184.26 96.32 109.85 240.32 86.44 89.73 81.24 57.54 0.00 Inventory Days 138.70 196.40 172.08 226.96 362.63 137.09 130.10 123.43 122.72 0.00 Payable days 261.71 316.66 148.22 198.71 262.47 62.88 68.69 64.15 51.65 0.00 Cash Conversion Cycle 40.60 64.00 120.18 138.09 340.48 160.65 151.14 140.51 128.61 0.00 Total Debt/Equity 0.17 0.13 0.14 0.12 0.11 0.12 0.12 0.13 -11.33 27.21 Interest Cover 0.56 -0.51 -0.66 -1.24 -3.74 2.18 2.72 2.76 2.12 2.02

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 371.91 358.90 370.51 353.89 363.45 364.25 333.28 316.44 0.00 ROA 0.03% -1.61% -0.33% 0.21% -2.00% 2.04% 2.90% 2.25% 2.23% ROE 0.06% -2.68% -0.52% 0.32% -2.89% 2.86% 4.01% 6.05% 3676.38% ROCE 2.31% -0.03% 0.43% 0.76% -0.26% 3.93% 5.79% 4.67% 4.61% Fixed Asset Turnover 0.26 0.26 0.27 0.26 0.24 0.28 0.30 0.26 0.28 Receivable days 77.38 74.96 80.42 76.23 95.27 91.33 78.87 78.60 60.82 Inventory Days 120.02 117.68 109.59 98.96 104.66 100.87 91.59 98.11 90.86 Payable days 172.74 141.75 145.87 147.90 176.50 49.83 43.67 37.47 22.81 Cash Conversion Cycle 24.66 50.89 44.14 27.28 23.44 142.37 126.80 139.24 128.86 Total Debt/Equity 0.36 0.35 0.31 0.26 0.20 0.18 0.19 0.21 238.62 Interest Cover 1.12 -0.02 0.36 0.93 -0.37 4.18 6.46 5.73 5.43

Top Investors:

mukul mahavir agrawal

massachusetts institute of technology

hbm healthcare investments (cayman) ltd

investor education and protection fund (iepf)

Annual Reports:

News Update:

Dishman Carbogen Amcis’ arm partners with Celonic Group
8th Oct 2025, 11:00 AM

The partnership is to offer a fully integrated Antibody-Drug Conjugate (ADC) development and manufacturing solution
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback